Published in Eur J Pediatr on March 01, 1999
The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry (1992) 4.54
Remembering the past: two facets of episodic memory explored with positron emission tomography. Am J Psychiatry (1995) 3.71
Broader autism phenotype: evidence from a family history study of multiple-incidence autism families. Am J Psychiatry (1997) 3.60
Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. Science (1994) 3.38
Schizophrenia and cognitive dysmetria: a positron-emission tomography study of dysfunctional prefrontal-thalamic-cerebellar circuitry. Proc Natl Acad Sci U S A (1996) 2.40
Course of behavioral change in autism: a retrospective study of high-IQ adolescents and adults. J Am Acad Child Adolesc Psychiatry (1996) 2.09
Improving tissue classification in MRI: a three-dimensional multispectral discriminant analysis method with automated training class selection. J Comput Assist Tomogr (1999) 2.06
Opportunistic infections and psychosocial stress in HIV. Am Fam Physician (1997) 2.03
An MRI study of the corpus callosum in autism. Am J Psychiatry (1997) 2.01
Symptoms of schizophrenia. Methods, meanings, and mechanisms. Arch Gen Psychiatry (1995) 2.00
Automatic atlas-based volume estimation of human brain regions from MR images. J Comput Assist Tomogr (1996) 1.99
Potential methane reservoirs beneath Antarctica. Nature (2012) 1.92
An MRI study of brain size in autism. Am J Psychiatry (1995) 1.92
An MRI study of autism: the cerebellum revisited. Neurology (1997) 1.86
Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics. Am J Psychiatry (1999) 1.72
Quantitative EEG differences in a nonclinical sample of children with ADHD and undifferentiated ADD. J Am Acad Child Adolesc Psychiatry (1996) 1.71
Regional brain enlargement in autism: a magnetic resonance imaging study. J Am Acad Child Adolesc Psychiatry (1996) 1.70
The impact of substance abuse on the course of bipolar disorder. Biol Psychiatry (2000) 1.67
Generalized cognitive deficits in schizophrenia: a study of first-episode patients. Arch Gen Psychiatry (1999) 1.61
Corpus callosum shape and size in male patients with schizophrenia. Biol Psychiatry (1998) 1.57
Ventricular enlargement in schizophrenia evaluated with computed tomographic scanning. Effects of gender, age, and stage of illness. Arch Gen Psychiatry (1990) 1.57
Morphometry in schizophrenia revisited: height and its relationship to pre-morbid function. Psychol Med (1998) 1.56
The role of gender in studies of ventricle enlargement in schizophrenia: a predominantly male effect. Am J Psychiatry (1990) 1.52
Ethylmalonic encephalopathy: clinical and biochemical observations. Neuropediatrics (2007) 1.49
Short-term and long-term verbal memory: a positron emission tomography study. Proc Natl Acad Sci U S A (1995) 1.45
Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life. Am J Psychiatry (1998) 1.44
fMRI of neuronal activation with symptom provocation in unmedicated patients with obsessive compulsive disorder. J Psychiatr Res (2001) 1.42
Regional brain abnormalities in schizophrenia measured with magnetic resonance imaging. JAMA (1994) 1.41
Anatomic and functional variability: the effects of filter size in group fMRI data analysis. Neuroimage (2001) 1.40
[Idiopathic facial palsy during pregnancy]. HNO (2012) 1.38
Caudate size in first-episode neuroleptic-naive schizophrenic patients measured using an artificial neural network. Biol Psychiatry (1999) 1.37
Infestation of rodents with larval Ixodes ricinus (Acari: Ixodidae) is an important factor in the transmission cycle of Borrelia burgdorferi s.l. in German woodlands. J Med Entomol (1995) 1.36
Positive and negative symptoms in schizophrenia. A critical reappraisal. Arch Gen Psychiatry (1990) 1.35
Effects of frequent marijuana use on brain tissue volume and composition. Neuroreport (2000) 1.27
Cognitive correlates of the negative, disorganized, and psychotic symptom dimensions of schizophrenia. J Neuropsychiatry Clin Neurosci (2000) 1.26
Effects of olanzapine on cerebellar functional connectivity in schizophrenia measured by fMRI during a simple motor task. Psychol Med (2001) 1.22
Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia. Am J Psychiatry (1999) 1.19
Functional MRI statistical software packages: a comparative analysis. Hum Brain Mapp (1998) 1.14
Neurological soft signs in neuroleptic-naive and neuroleptic-treated schizophrenic patients and in normal comparison subjects. Am J Psychiatry (1995) 1.13
Role of common gene variations in the molecular pathogenesis of short-chain acyl-CoA dehydrogenase deficiency. Pediatr Res (2001) 1.13
Genetic substructure in South African Bantu-speakers: evidence from autosomal DNA and Y-chromosome studies. Am J Phys Anthropol (2002) 1.11
Conjugal loss and syndromal depression in a sample of elders aged 70 years or older. Am J Psychiatry (1999) 1.10
Reversibility of brain tissue loss in anorexia nervosa assessed with a computerized Talairach 3-D proportional grid. Psychol Med (1996) 1.09
An improved thin-layer chromatographic method for urinary oligosaccharide screening. Clin Chim Acta (1979) 1.08
Cerebellar hypoactivity in frequent marijuana users. Neuroreport (2000) 1.06
II. PET studies of memory: novel versus practiced free recall of word lists. Neuroimage (1995) 1.05
Cerebellar size and cognition: correlations with IQ, verbal memory and motor dexterity. Neuropsychiatry Neuropsychol Behav Neurol (1997) 1.05
Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: a claims-based approach. Arch Gen Psychiatry (2001) 1.05
Symptom dimensions and brain morphology in schizophrenia and related psychotic disorders. J Psychiatr Res (1996) 1.02
Relationship between patient variables and plasma clozapine concentrations: a dosing nomogram. Biol Psychiatry (1998) 1.02
Aberrant respiratory sensitivity to CO(2) as a trait of familial panic disorder. Biol Psychiatry (2001) 1.02
Correlational studies of the Scale for the Assessment of Negative Symptoms and the Scale for the Assessment of Positive Symptoms: an overview and update. Psychopathology (1995) 1.01
Psychiatric disorders in children and adolescents after severe traumatic brain injury: a controlled study. J Am Acad Child Adolesc Psychiatry (1998) 1.01
Polarity sequence, depression, and chronicity in bipolar I disorder. J Nerv Ment Dis (1999) 0.99
Replacement therapy with a monoclonal antibody purified protein C concentrate in newborns with severe congenital protein C deficiency. Semin Thromb Hemost (1995) 0.98
Sample size and statistical power in [15O]H2O studies of human cognition. J Cereb Blood Flow Metab (1996) 0.97
Hyperinsulinaemic hypoglycaemia--leading symptom in a patient with congenital disorder of glycosylation Ia (phosphomannomutase deficiency). J Inherit Metab Dis (2001) 0.97
Hippocampus and amygdala in schizophrenia: assessment of the relationship of neuroanatomy to psychopathology. Psychiatry Res (2001) 0.97
Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults. Ann Clin Psychiatry (2001) 0.96
Mucopolysaccharidosis type VII (beta-glucuronidase deficiency): a report of a new case and a survey of those in the literature. Clin Genet (1982) 0.96
Segmentation techniques for the classification of brain tissue using magnetic resonance imaging. Psychiatry Res (1992) 0.96
Nitric oxide modulates expression of matrix metalloproteinase-9 in rat mesangial cells. Kidney Int (2000) 0.95
The Neuropsychiatric Rating Schedule: reliability and validity. J Am Acad Child Adolesc Psychiatry (1998) 0.94
The cerebellum plays a role in conscious episodic memory retrieval. Hum Brain Mapp (1999) 0.94
Stability of cognitive functioning early in the course of schizophrenia. Schizophr Res (1994) 0.93
The life course of schizophrenia: age and symptom dimensions. Schizophr Res (1997) 0.93
SLC3A1 and SLC7A9 mutations in autosomal recessive or dominant canine cystinuria: a new classification system. J Vet Intern Med (2013) 0.92
Attention-deficit hyperactivity symptomatology after traumatic brain injury: a prospective study. J Am Acad Child Adolesc Psychiatry (1998) 0.92
Posttraumatic stress symptomatology after childhood traumatic brain injury. J Nerv Ment Dis (1998) 0.92
I. PET studies of memory: novel and practiced free recall of complex narratives. Neuroimage (1995) 0.91
Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of response. J Clin Psychopharmacol (1994) 0.90
N-acetylaspartylglutamate in Canavan disease: an adverse effector? Eur J Pediatr (1999) 0.90
Factors associated with suicide attempts among patients with schizophrenia. Psychiatr Serv (1998) 0.90
Normomorphic sialidosis in two female adults with severe neurologic disease and without sialyl oligosacchariduria. Hum Genet (1986) 0.90
The effect of remission of poststroke depression on activities of daily living in a double-blind randomized treatment study. J Nerv Ment Dis (2001) 0.90
Fetal presentation of Morquio disease type A. Prenat Diagn (1992) 0.90
Effect of antipsychotic withdrawal on negative symptoms in schizophrenia. Neuropsychopharmacology (1994) 0.90
Premorbid adjustment as a predictor of phenomenological and neurobiological indices in schizophrenia. Schizophr Res (1995) 0.90
Population-based association analyses of the HOPA12bp polymorphism for schizophrenia and hypothyroidism. Am J Med Genet (2001) 0.89
Memory complaint in a community sample aged 70 and older. J Am Geriatr Soc (2000) 0.89
The Iowa prospective longitudinal study of recent-onset psychoses. Schizophr Bull (1992) 0.89
Replacement therapy with protein C concentrate in infants and adolescents with meningococcal sepsis and purpura fulminans. Semin Thromb Hemost (1999) 0.89
Are there symptoms that are specific for depressed mood in patients with traumatic brain injury? J Nerv Ment Dis (1993) 0.89
Auditory attentional deficits in patients with schizophrenia. A positron emission tomography study. Arch Gen Psychiatry (1996) 0.88
Alogia, attentional impairment, and inappropriate affect: their status in the dimensions of schizophrenia. Compr Psychiatry (1993) 0.88
Cognitive outcome in children and adolescents following severe traumatic brain injury: influence of psychosocial, psychiatric, and injury-related variables. J Int Neuropsychol Soc (1999) 0.88
Personality change disorder in children and adolescents following traumatic brain injury. J Int Neuropsychol Soc (2000) 0.88
Neural substrates of facial recognition. J Neuropsychiatry Clin Neurosci (1996) 0.87
The reliability of "bizarre" delusions. Compr Psychiatry (1991) 0.87
Urinary glycosaminoglycans in Graves' ophthalmopathy. Clin Endocrinol (Oxf) (1990) 0.87
Clinical and biochemical delineation of aspartyl-glycosaminuria as observed in two members of an Italian family. Helv Paediatr Acta (1981) 0.87
Enantioselective multidimensional gas chromatography-mass spectrometry in the analysis of urinary organic acids. J Chromatogr B Biomed Sci Appl (1998) 0.87
Recurrent vomiting and ethylmalonic aciduria associated with rare mutations of the short-chain acyl-CoA dehydrogenase gene. J Inherit Metab Dis (2003) 0.86
[Cochlear implant for malformations of the inner ear]. HNO (2009) 0.86
Liver transplantation in two cases of propionic acidaemia. J Inherit Metab Dis (1995) 0.84
No difference in hippocampus volume detected on magnetic resonance imaging in autistic individuals. J Autism Dev Disord (1998) 0.84
[Anesthesiological management of the EXIT procedure. Case report and literature review]. Anaesthesist (2005) 0.84
T1 and T2 relaxation times in schizophrenia as measured with magnetic resonance imaging. Schizophr Res (1991) 0.84
High rate of Bartonella henselae infection in HIV-positive outpatients in Johannesburg, South Africa. Trans R Soc Trop Med Hyg (2002) 0.84
A case of combined Farber and Sandhoff disease. Eur J Pediatr (1989) 0.83